Company
Vaxxas
Vaxxas is an Australian company specializing in needle-free vaccine delivery using its proprietary High Density Microarray Patch (HD-MAP) technology. The company focuses on enhancing the performance of existing and next-generation vaccines, with applications in infectious diseases and oncology. Vaxxas has established collaborations with global organizations, including Merck/MSD, the United States Biomedical Advanced Research and Development Authority (BARDA), the World Health Organization (WHO), the Coalition for Epidemic Preparedness (CEPI), and the Gates Foundation. The company has offices in Cambridge, Massachusetts, USA, and Hamilton, Queensland, Australia.
Investors
Investor